¼¼°èÀÇ ¼Ò¾Æ ½ÉÀå ¼ö¼ú ½ÃÀå
Pediatric Cardiac Surgery
»óǰÄÚµå : 1784001
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 273 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,666,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼Ò¾Æ ½ÉÀå ¼ö¼ú ¼¼°è ½ÃÀåÀº 2030³â±îÁö 256¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 166¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼Ò¾Æ ½ÉÀå ¼ö¼ú ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 7.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 256¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÀÎÅͺ¥¼Ç ½Ã¼úÀº CAGR 6.1%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 155¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸»ÃÊÇ÷°ü ½Ã¼ú ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 10.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 45¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 11.4%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼Ò¾Æ ½ÉÀå ¼ö¼ú ½ÃÀåÀº 2024³â¿¡ 45¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 53¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 11.4%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 3.8%¿Í 7.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¼Ò¾Æ ½ÉÀå ¼ö¼ú ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¼Ò¾Æ ½ÉÀå¼ö¼ú, ¼±Ãµ¼º ½ÉÀåÁúȯ Áõ°¡¿¡ ´ëÀÀÇÒ ¼ö ÀÖÀ»±î? Àü¹®Àû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

½Å»ý¾Æ ¼±Ãµ¼º ½ÉÀ庴(CHD)ÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î °í±Þ ¼Ò¾Æ ½ÉÀå ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. CHD´Â ½É¹æÁ߰ݰá¼ÕÁõ(ASD)°ú °°Àº ´Ü¼øÇÑ °áÇÔºÎÅÍ Á½ÉÀúÇü¼ºÁõÈıº(HLHS), ÆÄ·Î »ç¡Áõ(TOF)°ú °°Àº º¹ÀâÇÑ Áúȯ¿¡ À̸£±â±îÁö ´Ù¾çÇϸç, ¸¹Àº °æ¿ì ¼ö¼úÀû °³ÀÔÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¼Ò¾Æ ½ÉÀå¼ö¼úÀº ÃÖ¼Òħ½ÀÀû ½Ã¼ú, ·Îº¿ º¸Á¶ ½Ã¼ú, ¼ö¼ú °èȹÀ» À§ÇÑ 3D ÇÁ¸°ÆÃ ½ÉÀå ¸ðÇüÀÇ µµÀÔÀ¸·Î Å©°Ô ¹ßÀüÇß½À´Ï´Ù. Á¶±â Áø´Ü¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡´Â ÅÂ¾Æ ½ÉÀåÃÊÀ½ÆÄÀÇ ¹ßÀü°ú ÇÔ²² ¼ö¼ú ¼º°ø·üÀ» ³ôÀÌ°í ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» °¨¼Ò½Ã۰í ÀÖ½À´Ï´Ù. ¼Ò¾Æ ½ÉÀå¼¾ÅÍ´Â ´õ ³ªÀº ȯÀÚ °á°ú¸¦ º¸ÀåÇϱâ À§ÇØ ½ÉÀå Àü¹®ÀÇ, ¿Ü°úÀÇ»ç, ½Å»ý¾Æ Àü¹®Àǰ¡ ÅëÇÕµÈ ´ÙÇÐÁ¦Àû Á¢±Ù¹ýÀ» µµÀÔÇÏ¿© ¿ª·®À» È®ÀåÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ÁßÀú¼Òµæ ±¹°¡¿¡¼­ »ý¸íÀ» »ì¸®´Â ¼Ò¾Æ ½ÉÀå ¼ö¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ ÀÖ¾î Á¤ºÎÀÇ ³ë·Â°ú ºñ¿µ¸® ´Üüµµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ±â¼ú°ú ¼ö¼ú ±â¹ýÀÌ °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó ¼Ò¾Æ ½ÉÀå ¼ö¼ú ½ÃÀåÀº Å©°Ô ¼ºÀåÇÏ¿© ½ÉÀå Àå¾Ö ¾Æµ¿ÀÇ »ýÁ¸À² Çâ»ó°ú »îÀÇ Áú Çâ»óÀ» º¸ÀåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

AI, ·Îº¿ °øÇÐ, 3D ÇÁ¸°ÆÃ, ±â¼úÀÇ ¹ßÀüÀÌ ¼Ò¾Æ ½ÉÀå ¼ö¼ú¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù.

¼Ò¾Æ ½ÉÀå¼ö¼ú ºÐ¾ß¿¡¼­´Â AI, ·Îº¿°øÇÐ, 3D ÇÁ¸°ÆÃÀÌ ¼ö¼ú ±â¼ú Çõ½ÅÀ» ÁÖµµÇÏ¸ç ±â¼úÇõ¸íÀÌ ÀϾ°í ÀÖ½À´Ï´Ù. AI ±â¹Ý Áø´Ü µµ±¸´Â ½Ç½Ã°£ ¿µ»ó ºÐ¼®°ú º¹ÀâÇÑ ½ÉÀå ÀÌ»ó¿¡ ´ëÇÑ À§Çèµµ Æò°¡¸¦ Á¦°øÇÏ¿© ¼ö¼ú Àü °èȹÀ» °­È­ÇÕ´Ï´Ù. ·Îº¿ º¸Á¶ ¼ö¼úÀº ´õ ³ôÀº Á¤È®µµ, ÃÖ¼Òħ½À¼º, ȸº¹ ½Ã°£ ´ÜÃàÀ» ÅëÇØ °íÀ§Çè ½ÉÀå ¼ö¼úÀ» ¼Ò¾Æ ȯÀڵ鿡°Ô ´õ ¾ÈÀüÇÏ°Ô ¸¸µé¾îÁÖ°í ÀÖ½À´Ï´Ù. 3D ÇÁ¸°ÆÃÀº ¿Ü°ú Àǻ簡 ȯÀÚ °íÀ¯ÀÇ ÇØºÎÇÐÀû ±¸Á¶¿¡ µû¶ó »ó¼¼ÇÑ ½ÉÀå ¸ðµ¨À» ¸¸µé ¼ö ÀÖ°ÔÇÔÀ¸·Î½á ¼ö¼úÀÇ Á¤È®¼º°ú Ä¡·á °á°ú¸¦ Çâ»ó½Ã۰í, ¼ö¼ú °èȹÀÇ È¹±âÀûÀÎ ±â¼úÀÓÀÌ ÀÔÁõµÇ°í ÀÖ½À´Ï´Ù. ü¿Ü¸·»ê¼Ò¿ä¹ý(ECMO)°ú ¼Ò¾Æ º¸Á¶ Àΰø½ÉÀå(VAD)ÀÇ ¹ßÀüÀº ½ÉÀå À̽ÄÀ» ±â´Ù¸®´Â ÁßÁõ ȯ¾Æµé¿¡°Ô »ý¸íÀ» ±¸ÇÒ ¼ö ÀÖ´Â µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ýü°øÇÐ ½ÉÀåÆÇ¸·°ú Á¶Á÷°øÇÐ ÀÌ½ÄÆíÀº ±âÁ¸ÀÇ Àΰø½ÉÀåÀ» ´ëüÇÒ ¼ö ÀÖ´Â ´ë¾ÈÀ¸·Î ¶°¿À¸£°í ÀÖÀ¸¸ç, ¼Ò¾ÆÀÇ ¼ºÀå¿¡ µû¶ó ¹Ýº¹ÀûÀÎ ¼ö¼úÀÇ Çʿ伺À» ÁÙ¿©ÁÖ°í ÀÖ½À´Ï´Ù. ¼Ò¾Æ ½ÉÀå ¼ö¼úÀÇ ²÷ÀÓ¾ø´Â ±â¼ú Çõ½ÅÀ¸·Î »ýÁ¸À²°ú ¼ö¼ú ÈÄ °ü¸®°¡ °³¼±µÇ¾î CHD ¾î¸°À̵éÀÌ °Ç°­ÇÑ »îÀ» »ì ¼ö ÀÖ´Â ±âȸ°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

¼Ò¾Æ ½ÉÀå ¼ö¼úÀº ¾îµð¿¡¼­ ¼ºÀåÇϰí Àִ°¡? Áö¿ª µ¿Çâ°ú ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÌÇØ

¼Ò¾Æ ½ÉÀå¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â Àü ¼¼°èÀûÀ¸·Î È®´ëµÇ°í ÀÖÀ¸¸ç, ºÏ¹Ì¿Í À¯·´ µî ¼±Áø Áö¿ªÀÌ ÃÖ÷´Ü ¼ö¼ú ±â¼ú µµÀÔÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¼Ò¾Æ ½ÉÀå Àü¹® ¼¾ÅÍÀÇ Á¸Àç, Àß Á¤ºñµÈ ÀÇ·á ÀÎÇÁ¶ó, Á¤ºÎ Áö¿ø CHD °ËÁø ÇÁ·Î±×·¥ µîÀÌ ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× ¶óƾ¾Æ¸Þ¸®Ä«¿¡¼­´Â Ãâ»êÀ² Áõ°¡, ¼±Ãµ¼º ½ÉÀ庴¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Àú·ÅÇÑ °¡°ÝÀ¸·Î ¼Ò¾Æ ½ÉÀå ¼ö¼úÀ» ¹ÞÀ» ¼ö ÀÖ´Â ÀÇ·á °ü±¤ÀÇ Áõ°¡·Î ÀÎÇØ ½ÃÀåÀÌ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ºñ¿µ¸® ´Üü¿Í ±¹Á¦ Çù·ÂÀº °æÁ¦ÀûÀÎ Á¦¾àÀ¸·Î ÀÎÇØ »ó´ç¼öÀÇ CHD ȯÀÚ°¡ Ä¡·á¹ÞÁö ¸øÇϰí ÀÖ´Â ÀÇ·á ÇýÅÃÀÌ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ¼Ò¾Æ ½ÉÀå ¼ö¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» °³¼±Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï±¹ Á¤ºÎ´Â ¼Ò¾Æ ½ÉÀå Ä¡·á ÇÁ·Î±×·¥¿¡ ÅõÀÚÇϰí, ¼Ò¾Æ ½ÉÀå º´µ¿À» È®ÀåÇϰí, ¼±Ãµ¼º ½ÉÀ庴À¸·Î ÀÎÇÑ ºÎ´ã Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ´õ ¸¹Àº Àü¹® ¿Ü°ú Àǻ縦 ¾ç¼ºÇϰí ÀÖ½À´Ï´Ù. Á¶±â °³ÀÔ°ú ¿ì¼öÇÑ ¼ö¼ú¿¡ ´ëÇÑ Á߿伺ÀÌ Á¡Á¡ ´õ °­Á¶µÇ¸é¼­ ¼¼°è ¼Ò¾Æ ½ÉÀå ¼ö¼ú ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ç°íÀÚ ÇÕ´Ï´Ù.

¼Ò¾Æ ½ÉÀå ¼ö¼ú ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµË´Ï´Ù...

¼±Ãµ¼º ½ÉÀ庴(CHD)ÀÇ Àü ¼¼°è À¯º´·ü Áõ°¡°¡ ¼Ò¾Æ ½ÉÀå ¼ö¼ú ¼ö¿ä È®´ëÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼ú¹ý, ·Îº¿ º¸Á¶ ¼ö¼ú¹ý, ½Ç½Ã°£ ¿µ»ó±â¼úÀÇ ¹ßÀüÀ¸·Î ¼ö¼úÀÇ Á¤È®¼º°ú Ä¡·á ¼ºÀûÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¼ö¼ú Àü °èȹÀ» À§ÇÑ 3D ÇÁ¸°ÆÃÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¼ö¼ú À§ÇèÀ» ÁÙÀÌ°í ¼ö¼ú ¼º°ø·üÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¼Ò¾Æ º¸Á¶ Àΰø½ÉÀå(VAD) ¹× ECMO ½Ã½ºÅÛÀÇ »ç¿ëÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, ÁßÁõ ȯ¾Æ¿¡°Ô »ý¸íÀ» ±¸ÇÏ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. Á¤ºÎ¿Í ºñ¿µ¸® ´ÜüÀÇ ¼Ò¾Æ ½ÉÀå ÀÇ·á Á¢±Ù¼º Çâ»óÀ» À§ÇÑ ³ë·ÂÀ¸·Î °³¹ßµµ»ó±¹¿¡¼­ ¼ö¼ú °Ç¼ö°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. »êÀü ¼±º°°Ë»ç ¹× ½Å»ý¾Æ ½ÉÀåÃÊÀ½ÆÄ °Ë»ç¸¦ ÅëÇÑ CHDÀÇ Á¶±â ¹ß°ßÀÌ Áß¿äÇØÁö¸é¼­ Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¼Ò¾Æ ½ÉÀå¼¾ÅͰ¡ Áõ°¡Çϰí, ¼Ò¾Æ ½ÉÀå ¼ö¼ú Àü¹® ´ÙÇÐÁ¦ÆÀÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àü¹ÝÀûÀΠǥÁØ Ä¡·á°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. CHD¿¡ ´ëÇÑ ¸ÂÃãÀÇ·á¿Í À¯ÀüÀÚ ¿¬±¸°¡ Á¡Á¡ ´õ Áß¿äÇØÁö¸é¼­, Ç¥ÀûÈ­µÈ ¼ö¼úÀû Á¢±ÙÀÇ ±æÀÌ ¿­¸®°í ÀÖ½À´Ï´Ù. ±â¼ú, ¼ö¼ú Àü¹®¼º, ÀÇ·á ÀÎÇÁ¶ó°¡ Áö¼ÓÀûÀ¸·Î ¹ßÀüÇÔ¿¡ µû¶ó ¼Ò¾Æ ½ÉÀå ¼ö¼ú ½ÃÀåÀº Å©°Ô È®´ëµÇ¾î ½ÉÀ庴 ¾î¸°ÀÌÀÇ »ýÁ¸À²°ú »îÀÇ ÁúÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù.

ºÎ¹®

½Ã¼ú(ÀÎÅͺ¥¼Ç ½Ã¼ú, ¸»ÃÊÇ÷°ü ½Ã¼ú, ½ÉÀå¹Úµ¿°ü¸® ½Ã¼ú), ÃÖÁ¾»ç¿ë(º´¿ø, Àü¹® ¼¾ÅÍ, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Pediatric Cardiac Surgery Market to Reach US$25.6 Billion by 2030

The global market for Pediatric Cardiac Surgery estimated at US$16.6 Billion in the year 2024, is expected to reach US$25.6 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Interventional Procedures, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$15.5 Billion by the end of the analysis period. Growth in the Peripheral Vascular Procedures segment is estimated at 10.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.5 Billion While China is Forecast to Grow at 11.4% CAGR

The Pediatric Cardiac Surgery market in the U.S. is estimated at US$4.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.3 Billion by the year 2030 trailing a CAGR of 11.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Pediatric Cardiac Surgery Market - Key Trends & Drivers Summarized

Can Pediatric Cardiac Surgery Keep Up with Rising Congenital Heart Defects? The Growing Need for Specialized Interventions

The increasing prevalence of congenital heart defects (CHDs) among newborns has fueled the demand for advanced pediatric cardiac surgeries worldwide. CHDs, which range from simple defects like atrial septal defects (ASD) to complex conditions such as hypoplastic left heart syndrome (HLHS) and Tetralogy of Fallot (TOF), require surgical intervention in many cases. Pediatric cardiac surgery has evolved significantly with the introduction of minimally invasive techniques, robotic-assisted procedures, and 3D-printed heart models for surgical planning. The growing awareness of early diagnosis, coupled with advancements in fetal echocardiography, is improving surgical success rates and reducing postoperative complications. Pediatric heart centers are expanding their capabilities, incorporating multidisciplinary approaches that integrate cardiologists, surgeons, and neonatologists to ensure better patient outcomes. Government initiatives and non-profit organizations are also playing a crucial role in increasing access to life-saving pediatric cardiac procedures, particularly in low- and middle-income countries. As technology and surgical techniques continue to evolve, the pediatric cardiac surgery market is set to witness significant growth, ensuring better survival rates and improved quality of life for children with heart defects.

How Are Technological Advancements Revolutionizing Pediatric Cardiac Surgery? AI, Robotics & 3D Printing

The field of pediatric cardiac surgery is witnessing a technological revolution, with AI, robotics, and 3D printing leading the way in surgical innovations. AI-powered diagnostic tools are enhancing preoperative planning by providing real-time imaging analysis and risk assessment for complex cardiac anomalies. Robotic-assisted surgeries are allowing for greater precision, minimal invasiveness, and reduced recovery times, making high-risk cardiac procedures safer for pediatric patients. 3D printing is proving to be a game-changer in surgical planning, enabling surgeons to create detailed heart models based on patient-specific anatomy, improving surgical accuracy and outcomes. Advancements in extracorporeal membrane oxygenation (ECMO) and pediatric ventricular assist devices (VADs) are providing life-saving support for critically ill children awaiting heart transplants. Additionally, bioengineered heart valves and tissue-engineered grafts are emerging as alternatives to traditional prosthetics, reducing the need for repeated surgeries as children grow. With continuous innovation in pediatric cardiac surgery, survival rates and postoperative care are improving, giving children with CHDs a better chance at leading healthy lives.

Where Is Pediatric Cardiac Surgery Expanding? Understanding Regional Trends & Market Dynamics

The demand for pediatric cardiac surgery is growing globally, with developed regions such as North America and Europe leading the adoption of cutting-edge surgical technologies. The presence of specialized pediatric heart centers, well-established healthcare infrastructure, and government-backed CHD screening programs are driving market growth in these regions. In Asia-Pacific and Latin America, the market is expanding rapidly due to rising birth rates, increasing awareness of congenital heart diseases, and growing medical tourism for affordable pediatric heart surgeries. Non-profit organizations and international collaborations are working to improve access to pediatric cardiac surgeries in underserved regions, where a significant number of CHD cases remain untreated due to financial constraints. Governments in emerging economies are investing in pediatric cardiac care programs, expanding pediatric cardiac units, and training more specialized surgeons to address the growing burden of congenital heart defects. With an increasing emphasis on early intervention and surgical excellence, the global pediatric cardiac surgery market is set for sustained growth.

The Growth in the Pediatric Cardiac Surgery Market Is Driven by Several Factors…

The rising prevalence of congenital heart defects (CHDs) globally is the primary driver behind the growing demand for pediatric cardiac surgeries. Advances in minimally invasive surgical techniques, robotic-assisted procedures, and real-time imaging technologies are improving surgical precision and outcomes. The increasing adoption of 3D printing for preoperative planning is reducing surgical risks and enhancing procedural success rates. The expanding use of pediatric ventricular assist devices (VADs) and ECMO systems is providing life-saving support for critically ill children. Government and non-profit initiatives aimed at improving pediatric cardiac care accessibility are increasing the number of surgeries performed in developing countries. The growing emphasis on early CHD detection through prenatal screening and neonatal echocardiography is enabling timely interventions. The rising number of pediatric heart centers and multidisciplinary teams specializing in pediatric cardiac surgery is enhancing the overall standard of care. The increasing focus on personalized medicine and genetic research in CHDs is paving the way for targeted surgical approaches. As technology, surgical expertise, and healthcare infrastructure continue to evolve, the pediatric cardiac surgery market is poised for significant expansion, ensuring better survival rates and quality of life for children with heart conditions.

SCOPE OF STUDY:

The report analyzes the Pediatric Cardiac Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Procedure (Interventional Procedures, Peripheral Vascular Procedures, Heart Rhythm Management Procedures); End-Use (Hospitals, Specialty Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â